These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509 [TBL] [Abstract][Full Text] [Related]
6. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis. Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100 [TBL] [Abstract][Full Text] [Related]
7. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report]. Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110 [TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis. Takahashi H; Kawaguchi N; Nemoto Y; Hattori T J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198 [TBL] [Abstract][Full Text] [Related]
11. An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up. Hosaka A; Takuma H; Ohta K; Tamaoka A Intern Med; 2012; 51(21):3077-9. PubMed ID: 23124154 [TBL] [Abstract][Full Text] [Related]
12. Anti-MuSK positivity on plasmapheresis liquid in a double seronegative myasthenia gravis patient. Renard D; Candon S; Jacob M; Trusson R; Reboul P Acta Neurol Belg; 2018 Mar; 118(1):119-120. PubMed ID: 28608313 [No Abstract] [Full Text] [Related]